ÎåÐÇÌåÓýÖ±²¥

ÎåÐÇÌåÓýÖ±²¥

ÎåÐÇÌåÓýÖ±²¥ was Founded in 2002 with the Goal of Engineering Exquisite Enzymes for a Variety of Industries and Applications

Today, we are a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing by leveraging our proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.

We’ve engineered the enzymes that have enabled some of the biggest pharmaceutical products ever developed, including Januvia (sitagliptin), Lipitor (atorvastatin) and Paxlovid (nirmatrelvir). Our work has been recognized with multiple Green Chemistry Challenge Awards from the American Chemical Society and we are known for our platform’s proven ability to revolutionize enzyme performance by increasing activity, specificity, and stability. Building upon this legacy, today we are focused on applying our deep expertise to the enzymatic manufacturing of small interference ribonucleic acid (siRNA) therapeutics.

ÎåÐÇÌåÓýÖ±²¥ Fast Facts

Founded 2002
Headquarters Redwood City, CA
Total Employees ~200
Market Debut April 22, 2010
Stock Ticker CDXS
FY2023 $62 million*
*Excluding enzyme sales related to PAXLOVID
Our Culture

Our Culture

We are trailblazers, we are ambitious, we are resilient and we will transform the practice of medicine through the exponential expansion of RNA manufacturing. Learn more about the culture.

Our Culture
Our Technology

Our Technology

Our proprietary technology is at the heart of everything we do and will ultimately enable us to impact the lives of millions of patients globally. Learn more about the work we’re doing.

Our Technology
Our People

Our People

Each colleague brings a depth of experience, unique perspective, passion and grit to their work that allows ÎåÐÇÌåÓýÖ±²¥ to advance our purpose. Learn more about our people and what it means to be a Codexian.

Our People